LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
$351M |
| 2 |
iShares Core Total USD Bond Market ETF
IUSB
|
$313M |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$236M |
| 4 |
Apple
AAPL
|
$204M |
| 5 |
Microsoft
MSFT
|
$199M |
Top Sells
Sector Composition
| 1 | Technology | 7.91% |
| 2 | Financials | 3.36% |
| 3 | Healthcare | 2.8% |
| 4 | Consumer Discretionary | 2.72% |
| 5 | Industrials | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
4901
Tvardi Therapeutics, Inc. Common Stock
TVRD
$290M
| $45.9K | ﹤0.01% |
4,140
-60
| -1% | -$665 |
|
4902
CytomX Therapeutics
CTMX
$346M
| $45.2K | ﹤0.01% |
38,315
+2,000
| +6% | +$2.36K |
|
|
BLUE
4903
DELISTED
bluebird bio
BLUE
| $44.7K | ﹤0.01% |
4,304
-5,274
| -55% | -$54.8K |
|
4904
Douglas Elliman
DOUG
$255M
| $44.1K | ﹤0.01% |
24,087
+755
| +3% | +$1.38K |
|
4905
Sportsman's Warehouse
SPWH
$121M
| $43.9K | ﹤0.01% |
16,195
+925
| +6% | +$2.51K |
|
4906
Relmada Therapeutics
RLMD
$50.8M
| $43.7K | ﹤0.01% |
13,490
-1,938
| -13% | -$6.28K |
|
4907
Arbutus Biopharma
ABUS
$797M
| $43.7K | ﹤0.01% |
+11,347
| New | +$43.7K |
|
4908
Hyperfine
HYPR
$93.5M
| $42.9K | ﹤0.01% |
+39,700
| New | +$42.9K |
|
4909
Solid Power
SLDP
$740M
| $42.7K | ﹤0.01% |
31,645
+5,110
| +19% | +$6.9K |
|
4910
Ardagh Metal Packaging
AMBP
$2.13B
| $42.3K | ﹤0.01% |
11,209
-3,524
| -24% | -$13.3K |
|
4911
E.W. Scripps
SSP
$258M
| $41.6K | ﹤0.01% |
18,538
-2,338
| -11% | -$5.25K |
|
4912
Telos
TLS
$455M
| $41.4K | ﹤0.01% |
+11,533
| New | +$41.4K |
|
4913
Talkspace
TALK
$447M
| $40.1K | ﹤0.01% |
19,200
-5,082
| -21% | -$10.6K |
|
4914
PDS Biotechnology
PDSB
$56M
| $39.8K | ﹤0.01% |
10,412
| – | – |
|
|
ZOM
4915
DELISTED
Zomedica Corp.
ZOM
| $39.2K | ﹤0.01% |
285,975
+3,097
| +1% | +$425 |
|
4916
FiscalNote
NOTE
$62.1M
| $37.6K | ﹤0.01% |
2,446
| – | – |
|
|
BCTX
4917
Briacell Therapeutics
BCTX
$13.9M
| $37.5K | ﹤0.01% |
202
+125
| +162% | +$23.2K |
|
4918
Planet Labs
PL
$2.73B
| $37.4K | ﹤0.01% |
+16,768
| New | +$37.4K |
|
4919
Organogenesis Holdings
ORGO
$615M
| $37.2K | ﹤0.01% |
13,009
-5
| -0% | -$14 |
|
4920
Eos Energy Enterprises
EOSE
$1.95B
| $37.1K | ﹤0.01% |
+12,475
| New | +$37.1K |
|
4921
NextCure
NXTC
$13.2M
| $37K | ﹤0.01% |
2,250
-250
| -10% | -$4.11K |
|
4922
Angi Inc
ANGI
$823M
| $36.7K | ﹤0.01% |
1,421
+10
| +0.7% | +$258 |
|
|
CMCT
4923
Creative Media & Community Trust
CMCT
$5.33M
| $36.6K | ﹤0.01% |
+298
| New | +$36.6K |
|
|
SMR.WS
4924
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
| $36.6K | ﹤0.01% |
+11,500
| New | +$36.6K |
|
4925
iQIYI
IQ
$2.63B
| $36.2K | ﹤0.01% |
12,648
-2,080
| -14% | -$5.95K |
|